Latest Automation News

Page 8 of 99
Merino & Co cut its FY2026 loss by 20% as China revenue more than doubled, but group revenue declined and cash reserves fell sharply. The auditor highlighted a material uncertainty over the company’s ability to continue as a going concern.
Victor Sage
Victor Sage
30 Sept 2026
Felix Group Holdings grew FY26 revenue and contracted ARR after acquiring Nexvia, but operating losses and cash outflows widened sharply. The ASX-listed software company is now relying on a post-year-end capital raising while it narrows its strategy to Australia and New Zealand.
Sophie Babbage
Sophie Babbage
30 Sept 2026
EQ Resources has completed a sharp financial turnaround, moving from solvency concerns to a A$7.1 million FY2026 profit and A$28.2 million of cash. The recovery comes with lower annual production, serious safety shortcomings and substantial dilution, leaving execution as the test for its A$39 million Mt Carbine expansion.
Maxwell Dee
Maxwell Dee
30 Sept 2026
Metallium has moved Flash Joule Heating from tiny laboratory tests to multi-reactor campaigns in Texas, backed by feedstock contracts, offtake and A$125 million raised during FY2026. Yet the ASX-listed group remains pre-revenue, lost A$42.8 million and says continued access to funding is a material uncertainty.
Victor Sage
Victor Sage
30 Sept 2026
TradeWindow is targeting 13% to 18% revenue growth in FY27 and expects to approach EBITDA breakeven, while preparing to shift its primary listing from the NZX to the ASX. The freight software company also reported rising recurring revenue, stronger customer economics and NZ$4.0 million in cash at 30 June 2026.
Victor Sage
Victor Sage
29 Sept 2026
Li-S Energy has narrowed its FY26 loss and reached several commercialisation milestones, including a 2C Power Cell, international shipping approvals and its first lithium foil sale. But the ASX battery developer still needs customer offtake and fresh funding before its proposed 1 GWh manufacturing expansion can become reality.
Victor Sage
Victor Sage
29 Sept 2026
Heartland Group Holdings (NZX: HGH, ASX: HGH) more than doubled FY2026 net profit as margins widened, asset quality improved and its proposed TSB merger moved towards a shareholder vote. The bank also reported a 16% fall in restated emissions, though much of its climate-risk work remains incomplete or estimate-driven.
Victor Sage
Victor Sage
29 Sept 2026
Hallenstein Glasson delivered a sharp lift in FY2026 profit as sales, margins and Australian trading strengthened. The NZX-listed retailer also raised its full-year dividend to 69 cents per share, while warning that early FY2027 sales growth is unlikely to persist at the same pace.
Logan Eniac
Logan Eniac
29 Sept 2026
Global X ROBO Global Robotics and Automation ETF delivered a sharply higher annual profit, powered by fair-value gains across its robotics portfolio. But the fund disclosed that its net asset value has since fallen by more than 10%, leaving investors with a strong reported year and a materially weaker latest position.
Claire Turing
Claire Turing
28 Sept 2026
AUCyber has added approximately $1.34 million in annual recurring revenue from two Australian university contracts, including a new 12-month deal with the University of New England worth more than $600,000 a year. The cybersecurity provider is also bidding for a separate university engagement valued at about $5.5 million, although that opportunity remains uncontracted.
Victor Sage
Victor Sage
28 Sept 2026
Rubicon Water’s technology has been selected as part of a joint venture bid for a major Moroccan irrigation upgrade covering 69,600 hectares. The opportunity could become its largest EMEA contract, but formal execution remains subject to a 15-day appeal period and subsequent commissioning.
Victor Sage
Victor Sage
28 Sept 2026
EBR Systems has completed the FDA’s pre-approval inspection of its new Santa Clara manufacturing facility, receiving two Form 483 observations. The company says it expects to correct them in the fourth quarter and still anticipates approval by year-end, although the FDA has not yet made its final determination.
Victor Sage
Victor Sage
28 Sept 2026

Browse the archive

Full archive